<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31C8C3D6-0F45-4639-8C94-78C0C503AB52"><gtr:id>31C8C3D6-0F45-4639-8C94-78C0C503AB52</gtr:id><gtr:name>Genethon</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/72A01FCA-EC02-4B8C-BFAC-3E4BD601C455"><gtr:id>72A01FCA-EC02-4B8C-BFAC-3E4BD601C455</gtr:id><gtr:name>International Collaborative Effort for DMD</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/740620CE-EA7F-48B2-BE09-4511F7E4CE20"><gtr:id>740620CE-EA7F-48B2-BE09-4511F7E4CE20</gtr:id><gtr:name>MRC Functional Genetics Unit</gtr:name><gtr:address><gtr:line1>Department of Human Anatomy and Genetics</gtr:line1><gtr:line2>University of Oxford</gtr:line2><gtr:line3>South Parks Road</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 3QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/740620CE-EA7F-48B2-BE09-4511F7E4CE20"><gtr:id>740620CE-EA7F-48B2-BE09-4511F7E4CE20</gtr:id><gtr:name>MRC Functional Genetics Unit</gtr:name><gtr:address><gtr:line1>Department of Human Anatomy and Genetics</gtr:line1><gtr:line2>University of Oxford</gtr:line2><gtr:line3>South Parks Road</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 3QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31C8C3D6-0F45-4639-8C94-78C0C503AB52"><gtr:id>31C8C3D6-0F45-4639-8C94-78C0C503AB52</gtr:id><gtr:name>Genethon</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/72A01FCA-EC02-4B8C-BFAC-3E4BD601C455"><gtr:id>72A01FCA-EC02-4B8C-BFAC-3E4BD601C455</gtr:id><gtr:name>International Collaborative Effort for DMD</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E152F8DC-B44A-4592-BCC4-42CF9258AD52"><gtr:id>E152F8DC-B44A-4592-BCC4-42CF9258AD52</gtr:id><gtr:firstName>Kay</gtr:firstName><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137761449"><gtr:id>27B03239-A442-46AF-BF7D-A7F4FC0D7434</gtr:id><gtr:title>Molecular analysis of neuromuscular and neurological disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137761449</gtr:grantReference><gtr:abstractText>Duchenne muscular dystrophy (DMD) is a progressive muscle wasting disorder where patients usually die in their early twenties. Much is now known about the disease pathogenesis and we are using this information to develop novel approaches to treatment. We have collaborated with Summit plc in defining a first in class molecule for increasing the levels of a protein which can compensate for the protein which is missing in patients. This is being taken forward to Phase 2 trials by Summit plc. We have developed an improved assay to identify compounds which could follow on from this into the clinic. We are also developing ways in which to improve the effificiency of exon skipping in DMD which has shown great promise in clinical trials carrried out by other groups. 
Another aspect of the programme is to study genes expressed in the brain which, when mutated, cause movement and behavoural disorders. By finding out what these genes are, we will be able to identify important genes involved in brain development and function in man which may be relevant to human disease such Parkinsons disease and Amyotrophic lateral sclerosis. One of the mouse mutants is a model for schizophrenia.</gtr:abstractText><gtr:technicalSummary>Our research focusses on the development of a therapy for the devastating progressive wasting disease, Duchenne muscular dystrophy (DMD) and the use of animal models to study to study movement and behavioural disorders in man. It has been known for more than a decade that DMD is caused by the absence of the large muscle protein dystrophin, which results in a fragile muscle membrane. Patients are usually confined to a wheelchair before the age of twelve and die in their early twenties. There is currently no effective treatment. The development of therapy for DMD is challenging because dystrophin is a large structural protein that needs to be delivered to all muscles. We are focussing on the pharmacological up-regulation of the dystrophin-related protein, utrophin as this could be used for all patients independent of the type of mutation. We have collaborated with Summit plc in the high throughput screening for drugs which might increase levels of utrophin in muscle. One candidate drug, SMTC1100 is currently being taken forward to Phase 2 trials by Summit plc. We have developed an improved screening cell line in order to identify further drugs in the future.
The second approach to therapy involves exon skipping using U7snRNA AAV vectors. We are exploring ways of improving the efficiency of exon skipping and are investigating strategies for multiexon skipping so that this approach can be used to treat more patients with different mutations. 
We are analysing several mouse mutants which show movement and behavioural abnormalities. One mutant, named bella, is a recessive mutant which is deleted for the gene Oxr1. We have shown that Oxr1 is involved in protection of the cell in oxidative stress. Interestingly, Oxr1 levels are increased in the spinal cord of Amyotrophic lateral sclerosis (ALS) patients. In an animal model of the disease, Oxr1 levels are increased before the onset of symptoms. We are currently exploring the function of Oxr1 and its role in neurodegenerative diseases. It may be that OXr1 is an early marker of disease which may provide clues to approaches to delaying disease onset.
We have also identified a mouse with a mutation in SNAP-25, named blind-drunk, as a potential model for schizophrenia. We have demonstrated that these animals have abnormal circadian rhythms which are very similar to those seen in schizophrenia patients. We are currently investigating the gene expression changes which might underlie these observations. We are also exploring circadian rhythms in other mouse models of neurodegenerative diseases (Alzheimers, Parkinsons) as patients with these disorders also show sleep abnormalities. These studies may identify new pathways which could be targeted for therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>8088737</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>Sleep and Circadian Neuroscience Institute</gtr:description><gtr:id>F043236D-792A-422D-AC27-BCDDA95A5D63</gtr:id><gtr:impact>No output yet</gtr:impact><gtr:outcomeId>MuS7KXKR9xb-1</gtr:outcomeId><gtr:partnerContribution>The collaboration is led by Professor Russell Foster and KED is part of the management committee. We provide input into the mouse models of schizophrenia</gtr:partnerContribution><gtr:piContribution>I am co-PI through the University for a Wellcome Trust Strategic Award</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>EU TREAT-NMD</gtr:description><gtr:id>E9F9B905-8408-4E8C-86C1-1801BBADCE0F</gtr:id><gtr:impact>A Report on the Development of new Screening Assays.</gtr:impact><gtr:outcomeId>76ABA6B9DEF-1</gtr:outcomeId><gtr:partnerContribution>Enabled information to be shared between a wide range of European Collaborators.</gtr:partnerContribution><gtr:piContribution>Our aim is to develop standardised screening assays for MD and SMA and validate such assays with a small number of reference compounds; the actual screening of compound libraries using these assays is outside the scope of TREAT-NMD.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Collaborative Effort for DMD</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>ICE - International Collaborative Effort for DMD</gtr:description><gtr:id>526653BB-6263-4422-A656-F8BFC4E7C9C4</gtr:id><gtr:impact>We have developed a method for increasing the efficiency of exon skipping.</gtr:impact><gtr:outcomeId>565F6E9745E-1</gtr:outcomeId><gtr:partnerContribution>They send us Exon skipping constructs for us to test in the utrophin/dystrophin double mutant mouse</gtr:partnerContribution><gtr:piContribution>We contribute new constructs for more efficient exon skipping.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>Exon skipping and miRNA analysis in DMD</gtr:description><gtr:id>76CE4A52-748F-47E9-B0DA-25DC58B9FBBD</gtr:id><gtr:impact>Publication: Crisp Alastair (Feb, 2011) Diaphragm rescue alone prevents heart dysfunction in dystrophic mice., Human molecular genetics 20, 3, 413-21</gtr:impact><gtr:outcomeId>mkmSnYuVxX1-1</gtr:outcomeId><gtr:partnerContribution>Preparation and evaluation of peptide conjugated oligonucleotides for exon skipping</gtr:partnerContribution><gtr:piContribution>Double knock-out mouse model of DMD and delivery of antisense oligonucleotides to mouse model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>Identification of ENU Mouse Mutants</gtr:description><gtr:id>0F8FB62A-12F0-4C2F-A3D5-B3ACC5D6613E</gtr:id><gtr:impact>Numerous publications covering the mutants 'Robotic', 'Blind-drunk', 'Moonwalker' and follow up studies.</gtr:impact><gtr:outcomeId>d5frptavSpo-1</gtr:outcomeId><gtr:partnerContribution>Provision of ENU mouse mutants for research into neurodegenerative diseases</gtr:partnerContribution><gtr:piContribution>Using the ENU mutagenesis resource we have identified several valuable new mouse models of neurological disease</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>Spinal Muscular Atrophy</gtr:description><gtr:id>199B53E8-9377-4C0D-A96D-F647DDF0D7FE</gtr:id><gtr:impact>Publication: Turner, B.J., Ackerley, S., Davies, K.E., and Talbot, K. (2010). Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Hum Mol Genet 19, 815-824.</gtr:impact><gtr:outcomeId>ppBfUoRgZ4Y-1</gtr:outcomeId><gtr:partnerContribution>Provides direct link to clinicians to increase relevance of work and promote translational research</gtr:partnerContribution><gtr:piContribution>Planning and execution of experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genethon</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Exon skipping and miRNA analysis in DMD</gtr:description><gtr:id>D89FD765-F5C7-410E-9379-7B49F39B8934</gtr:id><gtr:impact>Publication: Crisp Alastair (Feb, 2011) Diaphragm rescue alone prevents heart dysfunction in dystrophic mice., Human molecular genetics 20, 3, 413-21</gtr:impact><gtr:outcomeId>mkmSnYuVxX1-2</gtr:outcomeId><gtr:partnerContribution>Preparation and evaluation of peptide conjugated oligonucleotides for exon skipping</gtr:partnerContribution><gtr:piContribution>Double knock-out mouse model of DMD and delivery of antisense oligonucleotides to mouse model</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Bryce Memorial Lecture - Somerville College, Oxford, 2006</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1A83271C-2795-40E5-8ACF-4EAB93D37516</gtr:id><gtr:impact>Lecture entitled &amp;quot;Duchenne muscular dystrophy: past, present and future&amp;quot;

Education of laypeople within Oxford of the impact of genetics research on clinical treatment of disease</gtr:impact><gtr:outcomeId>88BA67B8BB2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sky News Interview March 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>636B0455-E0C0-43B8-9793-9D55F1CEA49D</gtr:id><gtr:impact>Sky News Interview on utrophin modulation and the collaboration between Summit plc and charities. - 13th March 2014

Greater national public awareness of research on muscular dystrophy being undertaken within the Unit</gtr:impact><gtr:outcomeId>544799a7ba7379.96152752</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture (2011) at the Academy of Medical Sciences</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2B69F9A5-7F78-4B0A-94C7-49AEC5BAF780</gtr:id><gtr:impact>&amp;quot;Treatments for Duchenne muscular dystrophy&amp;quot; - Research Reception for Muscular Dystrophy Campaign held at the Academy of Medical Sciences, London. 23rd June 2011.

Greater awareness by charity and patient group of latest research on Duchenne Muscular Dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>ZKVdg3NQUbc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dinner discussion on genomics and the NHS, 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>93477AA2-80C1-455C-9138-889BD07EBFDC</gtr:id><gtr:impact>The impact of genomic sequencing on the NHS and how thus could be introduced for maximum advantage to the UK was discussed with major representative from the media, researchers and the Secretary of State for Science, David Willette

Jouranlists followed through with articles on topics with the researchers</gtr:impact><gtr:outcomeId>U8dUNwweDr7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>100 leading practising scientists 2014</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D511AEBF-F31B-4BA0-A01C-BDEE0DD06C69</gtr:id><gtr:impact>Professor Dame Kay Davies was included within the list of the Science Council's &amp;quot;100 leading practising scientists&amp;quot; in the UK in 2014

Greater awareness of women in science and research on muscular dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>5447adcb8e3705.21940430</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.sciencecouncil.org/content/100-leading-uk-practising-scientists</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview to help with Eli's Fund 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F1B9580C-0ED6-4433-BCD6-452EB323AE1B</gtr:id><gtr:impact>Interview to help with Eli's Fund.


To raise awareness of muscular dystrophy and ongoing research to tackle disease</gtr:impact><gtr:outcomeId>UBjk2LRRanb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast for University of Oxford website 2010</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B85DDDD5-73B3-4E6E-90A4-65DFB892F421</gtr:id><gtr:impact>Pod Cast recorded for the University Website - November



Greater public awareness of research on being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>MiP1A3BaxN6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in Science conference - Said Business School, Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FF1D9619-9316-449B-A0DA-64151EBD89EC</gtr:id><gtr:impact>Was participant in the Women in Science Conference held at the Said Business School, Oxford, 1st November 2007

Provided Oxford's young women with greater awareness of the career and leadership opportunities available to them and fostered new connections between women currently pursuing a career in Science, Engineering and Technology.</gtr:impact><gtr:outcomeId>867FF62E71A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Laboratory visit by members of Muscular Dystrophy Campaign, 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>010F6982-EC44-452F-B1E2-D30C908CE825</gtr:id><gtr:impact>Visit to FGU labs by members of Muscular Dystrophy Campaign. Presentations by Prof Kay Davies and Dr Rebecca Fairclough followed by tour of the laboratory.
19 August 2013

Greater awareness of research on muscular dystrophy being undertaken by the Unit and MRC and understanding of the laboratory environment in which MDC funded research is being undertaken</gtr:impact><gtr:outcomeId>Ng2CABsKS6k</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture - Kingston University, June 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B22D75C8-E493-4635-AE7A-8CCB0354FF45</gtr:id><gtr:impact>Talk entitled &amp;quot;Progress in therapy for Duchenne muscular dystrophy: reason for optimism&amp;quot; - Kingston University Rose Lecture Series. 


Greater awareness of research on muscular dystrophy being undertaken by the Unit and MRC for patient groups and the general public</gtr:impact><gtr:outcomeId>RMrGpLfqnFF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Woodstock Society, Oxfordshire</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>287F9550-ED78-43DC-BF17-DEC4EF534A41</gtr:id><gtr:impact>Public lecture entitled: &amp;quot;Genetics in medicine in the 21st Century&amp;quot;

Greater public awareness of developments in the field and of research work being done locally</gtr:impact><gtr:outcomeId>7373344FE8C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Oxford Mail , 2010</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4F524391-E846-4B32-923E-BA9976A65F11</gtr:id><gtr:impact>Oxford Mail interview regarding Oxford Town and Gown Run on behalf of the Muscular Dystrophy Campaign.

Greater local public awareness of research on Muscular Dystrophy being done by the Unit and MRC</gtr:impact><gtr:outcomeId>Xx7YpgvENSi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>100 Leading Ladies - Portrait and interview (2014)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82C184AB-A8D6-4388-B97A-AD712B63DCCD</gtr:id><gtr:impact>Professor Dame Kay Davies included in Nancy Honey's 2014 book and exhibition of &amp;quot;100 Leading Ladies - portraits and interviews with influential senior women in Britain&amp;quot;

Raising public awareness of women in science and research on muscular dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>5447a8200d8ce5.74646537</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.thesorority.org/100leadingladies.asp</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk - Oxford Neuronetwork Early Career Discussion Group, Aug 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1E3B21C6-6151-4606-ADD4-B85CA8FE4A42</gtr:id><gtr:impact>Senior Investigator Scientist (PO, Davies Group) gave a talk on 'Behavioural phenotypes: how to make your animal models meaningful' at the Oxford Neuronetwork Early Career Discussion Group.


Greater awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>Vf2dyrRGW2c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured in Chain-Florey Brochure 2012</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C6A96C3A-F536-4974-84C4-4946465E9DE8</gtr:id><gtr:impact>Interview featured in Chain-Florey Brochure for meeting celebrating the scheme for Clinical Training Fellows at the MRC CSC, Hammersmith, 2012.


Greater awareness of women in science and research on muscular dystrophy and genomics being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>eZC3m2SZZFJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature in Stylist Magazine, Dec 2011</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>588F4A6B-6F11-4D25-B9EB-963C6326E7EE</gtr:id><gtr:impact>&amp;quot;How women turn into their mothers&amp;quot; Quote in a feature for Stylist Magazine by Naomi Reilly.


Raised awareness of women in science</gtr:impact><gtr:outcomeId>GqVsNHUKVeD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in Oxford Mail (April 2014)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4BFA6C49-D2F9-48D8-84D5-7DE2E09E86E9</gtr:id><gtr:impact>Featured and quoted in an Oxford Mail Article &amp;quot;Running the Town and Gown will help fund new treatment&amp;quot; - 9th April 2014. To encourage public to take part in Town and Gown 10k run to help raise funding for Muscular Dystrophy campaign.

Hopefully increased public participation in the race and fundraising. Also raised local awareness of research on muscular dystrophy being undertaken by the Unit</gtr:impact><gtr:outcomeId>54479db681a7f8.61377776</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.oxfordmail.co.uk/news/11134574.___Running_the_Town_and_Gown_will_help_fund_new_treatment___/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured in New Scientist article, Jan 2012</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>198DB765-F7A8-47A4-BECB-C9F93D5C7929</gtr:id><gtr:impact>Senior Investigator Scientist (PO Davies Group) work covered in New Scientist article: Disrupted body clock may prime you for schizophrenia, http://www.newscientist.com/article/dn21371-disrupted-body-clock-may-prime-you-for-schizophrenia.html


Greater public awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>tHUviefxK4s</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newscientist.com/article/dn21371-disrupted-body-clock-may-prime-you-for-schizophrenia.html</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview- Oxford Student Radio 2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E1E68471-F822-4EA5-8681-5212CBE0D9D5</gtr:id><gtr:impact>Interview about research for the Weekly Science News Bulletin for Oxford Student Radio. 123th May 2011

Greater awareness of the students as to muscular dystrophy research, potential career opportunities in medical research and opportunities for women in science. Increased profile of both the Unit and MRC.</gtr:impact><gtr:outcomeId>Sw9GzB5cL83</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Cafe Scientifique, Isle of Wight, Apr 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D41A64BA-76BA-4232-B999-F9F74E5F02E2</gtr:id><gtr:impact>Senior Investigator Scientist (PO, Davies Group) led a Cafe Scientifique in the Isle of Wight on 'Have I Got Snooze for You?'


Greater public awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>VGPNHp8SREx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press conference - winner of SET award for Science and Technology</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8D0A5995-7853-4A70-A5C6-3F6ACDF884F8</gtr:id><gtr:impact>Press conference after winning SET award for Women of Outstanding Achievement

This was to increase the profile of successful women in science and technology to younger scientists.</gtr:impact><gtr:outcomeId>4437F640BC8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with the Guardian Newspaper, 2011</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>96D805EB-A02B-48B7-AFF1-6B46ABB231BF</gtr:id><gtr:impact>An interview for the Guardian Newspaper about Muscular Dystrophy, January 2011

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>BctBKxhUGA2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Cafe Scientifique, Didcot Jan 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>27CDC0FC-56D5-4098-860A-CDE1D3533E32</gtr:id><gtr:impact>Senior Investigator Scientist (PO, Davies Group), led a Cafe Scientifique in Didcot entitled 'Have I Got Snooze for You?'. January 2011.

Greater local public awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>Mw6Q4QmzuEU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parent Project UK - Annual Conference</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>34FDBD64-4F30-4E1F-9597-47FCEE68CE98</gtr:id><gtr:impact>Lecture entitled: &amp;quot;Utrophin in the therapy of Duchenne muscular dystrophy&amp;quot; in terms that patients and their families could understand.

Better awareness within the patient population and also awareness in the funders of what resources are needed to take these treatments to the clinic</gtr:impact><gtr:outcomeId>04C207FC5EB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Cafe Scientifique, Wallingford May 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>ED6AD989-A2DE-4219-9F20-811F05FA76C6</gtr:id><gtr:impact>Senior Investigator Scientist (PO, Davies Group), led a Cafe Scientifique in Wallingford entitled 'Have I Got Snooze for You?'
23 May 2011

Greater local public awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>CJyUstVWk2K</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Future Science Leaders Workshop , 2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A71136F7-181D-40ED-BE26-F6C30FAFFE06</gtr:id><gtr:impact>&amp;quot;Overcoming challenges: acquiring confidence in research&amp;quot; - Future Science Leaders Workshop, Rosalind Franklin Workshop, St John's College, Oxford, 13th September 2011

Greater awareness of the students as to muscular dystrophy research, potential career opportunities in medical research and opportunities for women in science. Increased profile of both the Unit and MRC.</gtr:impact><gtr:outcomeId>TVJGYgsE71D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science interview with journalist from The Times</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1D9E8ED0-E273-4EA3-A68C-974D5B364312</gtr:id><gtr:impact>Science Interview with Mark Henderson from the Times on exon skipping strategy, Oct 2009. Review appeared in The Times, Science Blog.

More patient awareness. Patients contacted the Unit</gtr:impact><gtr:outcomeId>462FEA7EFFF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Perth, Australia</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C80B5E14-7E6E-4DE9-9B3A-9E59FA7FBC2C</gtr:id><gtr:impact>Free public lecture on &amp;quot;Approaches to muscular dystrophy therapy: the partnership between patients, clinicians and biotechnology&amp;quot; organised by The Indian Ocean Rim Muscle Colloquium and the Institute of Advanced Studies

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>731EB9E07A3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Laboratory tour for Muscular Dystrophy Campaign, 2007</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8B6D40FA-8443-4E83-B7D8-BE046528C204</gtr:id><gtr:impact>Provided a tour of the laboratories in the Oxford Centre for Gene Function, where FGU is based, for laypersons involved with the Muscular Dystrophy Campaign

Greater awareness of the work being undertaken by the Unit/MRC into Muscular Dystrophy and better understanding of the research laboratory environment in which the work is being conducted</gtr:impact><gtr:outcomeId>58F69D174A4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Cafe Scientifique, Blackwells, Oxford</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6927584D-07F0-4DBC-94B3-4CD8DE0C281F</gtr:id><gtr:impact>Lecture entitled: &amp;quot;Finding Your Genes - The Challenges of Gene Therapy&amp;quot;.

Greater local public awareness of developments in the field and of research work being done by the Unit and MRC</gtr:impact><gtr:outcomeId>94F845E7672</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Natural Science Museum Oxford 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F95A6478-5CF8-48C9-A55A-F564ADB120A6</gtr:id><gtr:impact>&amp;quot;Muscular Dystrophy in the new genetics era&amp;quot; - Natural Science Museum, Oxford - November

Greater local public awareness of research on Muscular Dystrophy being done by the Unit and MRC</gtr:impact><gtr:outcomeId>YkRXTf8EzB9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Oxford Mail for Town and Gown Fun Run. 2013</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BB28A279-611C-45AD-9AC8-22851A9F5F0E</gtr:id><gtr:impact>Interview for Oxford Mail for Town and Gown Fun Run. 27th March

Greater local public awareness of research on Muscular Dystrophy being done by the Unit and MRC</gtr:impact><gtr:outcomeId>oWcmy8QLyUw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Laboratory tour (2009) - Wembley school children</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4A82B036-DA0A-4B40-9383-DCE2F7375F25</gtr:id><gtr:impact>Pupils from a secondary school in Wembley visited the Unit and were given a tour of the laboratories by post doc members of the Davies research group

Greater awareness of the students as to the type of medical research being undertaken by the Unit/MRC, experience of a high tech lab environment and increased awareness of potential career opprotunities in science.</gtr:impact><gtr:outcomeId>3A7C3D2BA2B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Australian Broadcasting Association, 2009</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BCA52CC6-A1EA-4FB5-9D94-166764EC4085</gtr:id><gtr:impact>Interview with Robyn Williams for the Science Show, Australian Broadcasting Association.

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>3A7392107B0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Osler Lecture - Said Business School, Oxford 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D99BA746-F973-461C-B53F-B7E72E083100</gtr:id><gtr:impact>Lecture entitled &amp;quot;Therapy for muscular dystrophy in the new genetics era&amp;quot; - Osler Lecture, Said Business School, Oxford

Greater local public awareness of developments in the field and of research work being done by the Unit and MRC</gtr:impact><gtr:outcomeId>ikvDN2aRFFp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview/video for the Physiology Society &quot;Genomics and Physiology&quot; 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1912AE18-F263-46C7-BA2E-DF46E08D5948</gtr:id><gtr:impact>Interview/video for the Physiology Society &amp;quot;Genomics and Physiology&amp;quot; 21st March 2013

Greater national awareness/understanding of genomics and the work of both the FGU and MRC</gtr:impact><gtr:outcomeId>EQQ85b2vq3e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Telephone/video interview - Royal Society</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D87C73A3-6A99-4885-B397-A92616B2B0D2</gtr:id><gtr:impact>Telephone/video Interview for The Royal Society 350th Anniversary Campaign

This was to increase Society's awareness of the impact of science and was part of the 350 anniversary year celebrations</gtr:impact><gtr:outcomeId>20C3CD90014</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ambassador, The Magnet Project, Science.  Oxford. 2011-</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6848D466-8E25-4D4C-A8C4-BFC9581D960C</gtr:id><gtr:impact>Ambassador, The Magnet Project, Science. Oxford. 2011-

Promoting science within the region and raising profile of the work of both the FGU and MRC</gtr:impact><gtr:outcomeId>WiPxTybAA84</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit- Putney High School 2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F0C75F68-746A-41A8-9E24-C157FCB3B45F</gtr:id><gtr:impact>&amp;quot;25 years in muscular dystrophy research- scientific and personal challenges.&amp;quot; A talk at Putney High School, London, 10th February 2011

Greater awareness of the pupils as to muscular dystrophy research, potential career opportunities in medical research and opportunities for women in science. Increased profile of both the Unit and MRC.</gtr:impact><gtr:outcomeId>eXrusiwNtjc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast for Physiological Society 2010</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D08FF0AB-F63D-4C2B-ABBB-DFC061C36A33</gtr:id><gtr:impact>&amp;quot;Progress in therapy for muscular dystrophy&amp;quot; - Podcast, The Physiological Society - July 2010

Greater public awareness of research on Muscular Dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>AfaXkQTRy6S</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Video interview contribution to MRC Centenary Programme film</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EA45CD7E-4C79-4797-9BD5-280EF329C561</gtr:id><gtr:impact>Video for the MRC Centenary Programme criterion 'To improve staff knowledge and understanding of both the aims and strategy of the MRC'. 29th July.

Improved staff knowledge and understanding of both the aims and strategy of the MRC.</gtr:impact><gtr:outcomeId>AcadyKBxuMm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Matthew Arnold School, Oxford</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>924B59EB-0CC9-49C5-B71C-9BA0EC7D70A0</gtr:id><gtr:impact>Investigator Scientist represented FGU at two annual Careers Days organised by MRC and involving relevant local employers to advise children on careers in science

Greater awareness of the pupils as to the breadth of opportunities available from a scientific career. Increased profile for the work of both the Unit and MRc within the local community.</gtr:impact><gtr:outcomeId>9538FD9162D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk - Guest of Honour, Livery Ladies Dinner, Nov 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DDB4C97D-A602-4C1D-B46B-92B3614A275B</gtr:id><gtr:impact>&amp;quot;Role of genetics in society&amp;quot; - Merchant Taylors Sichel, London - Guest of Honour, Livery Ladies Dinner - 13th November.

Greater national awareness of genomics research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>Aw3KupBnm7Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Portraits Display Event - Hertford College, Oxford (2014)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A4682075-65E1-46AA-922C-D2AC853EA417</gtr:id><gtr:impact>Press releases and portrait exhibition - Professor Dame Kay Davies' portrait was amongst those hung in Hertford College great hall to celebrate/raise the profile of female fellows and graduates

Raised awareness of women in science</gtr:impact><gtr:outcomeId>5447b9ac121f26.19920355</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.theguardian.com/education/2014/sep/21/oxford-hertford-college-portraits-women-co-ed</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Museum Lecture Theatre, Oxford 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>500D43C3-EEEA-4862-9DF6-BCB6F52444AE</gtr:id><gtr:impact>Lecture entitled &amp;quot;Muscular dystrophy in the new genetics era&amp;quot; - 150th Anniversary Lecture Series, Michaelmas Term 2010, Museum Lecture Theatre, Oxford.

Greater local public awareness of developments in the field and of research work being done by the Unit and MRC</gtr:impact><gtr:outcomeId>sqr81LRqYGq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture- The Times Cheltenham Festival Science 11 (2011)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D5BDE7B0-45C9-434C-956E-DD6E8ED4E2F9</gtr:id><gtr:impact>&amp;quot;About a boy: a solitary X chromosome.&amp;quot; The Times Cheltenham Festivals Science 11, Cheltenham, 8th June 2011

Greater public awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>te9GoP4WhXR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk - Women in Science (University of Oxford Athena Swan group)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B1965B12-C525-4A56-A3D7-24BCA26ABB4C</gtr:id><gtr:impact>Professor Dame Kay Davies gave a talk entitled &amp;quot;Life as a woman in science to the Women in Science in South Parks Road (Athena Swan) - A Seminar Series for Everyone Interested in Equality and Diversity. This resulted in more discussion on how women can succeed in science.



Greater awareness amongst women scientists of opportunities open to them</gtr:impact><gtr:outcomeId>5447b7ce135e91.80433537</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public meeting - MRC Council</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3D3FB949-45DC-46C7-AE21-08E260FCF31B</gtr:id><gtr:impact>Speaker: MRC Council &amp;quot;Faces of Medical Research&amp;quot;- public meeting

Greater public awareness of type of medical research being undertaken by FGU/MRC and increased profile of women in science</gtr:impact><gtr:outcomeId>B576523C810</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> '50 Movers and Shakers in Biobusiness, 2014' list</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8E74B5DA-3079-4CA6-8C9C-C16451C7EA18</gtr:id><gtr:impact>Professor Dame Kay Davies has been included in a special report on '50 Movers and Shakers in Biobusiness, 2014' which identifies 50 women in biobusiness in the UK who are challenging norms and bringing better health to people around the world.

Greater awareness of women in science and research being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>5447afe6acc1b8.66797293</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.onenucleus.com/news?id=4340</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Perth, Australia 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A195CE86-8557-4775-89A2-667CFB55D07E</gtr:id><gtr:impact>&amp;quot;What about Duchenne muscular dystrophy in the new genetics era?&amp;quot; Lecture at the Australian Neuromuscular Disease Research Institute

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>ZK2PNDFtQMt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article for the New Statesman website 2013</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5351EAF7-6A5D-4A51-A67C-E478E9380F24</gtr:id><gtr:impact>&amp;quot;Women in Science&amp;quot; - Article for the New Statesman website. September 2013







Raised awareness of women in science</gtr:impact><gtr:outcomeId>GDMWAx513NL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newstatesman.com/2013/09/macho-world-scientific-research</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview - Desert Island Discs, Radio 4, 2009</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B65FBAC-5867-4F2A-848F-37BD29392FE5</gtr:id><gtr:impact>One of Radio 4's most popular and enduring programmes. Created by Roy Plomley in 1942, the format is simple; each week a guest is invited by Kirsty Young to choose the eight records they would like to take with them to a desert island.

Increased personal profile and greater public awareness of Duchenne Muscular Dystrophy and the research being undertaken to combat the disease</gtr:impact><gtr:outcomeId>BAAB3840C2B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/radio4/features/desert-island-discs/castaway/f970b62d</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media releases - 10th anniversary of genome 2010</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53693EF4-9431-4568-AD4F-216FB23C4521</gtr:id><gtr:impact>Contributed to media releases on the 10th Anniversary of the draft of the human genome, Oxford.

Greater international awareness of involevment of both the FGU and MRC in genomics research</gtr:impact><gtr:outcomeId>nJBfYDgLxJu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speech to HRH Princess Royal 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5DA6CFBC-E68F-4CBF-A4A2-29A92E9F1546</gtr:id><gtr:impact>A speech to the HRH Princess Royal at a meeting of the Motor Neuron Disease Association, 1st November 2011

High profile public awareness of the work of both the FGU and MRC</gtr:impact><gtr:outcomeId>ecb8Giign3X</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk - The Times Cheltenham Science Festival, June 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>501CCB33-41AC-4E99-BD95-A2AD030B77F6</gtr:id><gtr:impact>Talk &amp;quot;Do you want your genome sequenced?&amp;quot; Cheltenham Editions at The Times Cheltenham Science Festival


Greater international awareness of involvement of both the FGU and MRC in genomics research</gtr:impact><gtr:outcomeId>UWio4fkCRHs</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Cafe Scientifique, Reading Oct 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B89BEC8D-7C4B-4517-BFC2-5177A4C2C02E</gtr:id><gtr:impact>Senior Investigator Scientist (PO, Davies Group), led a Cafe Scientifique in Reading entitled 'Have I Got Snooze for You?'. 17 Oct 2011

Greater local public awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>mRcjMSJ58ff</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in STEM conference, Harwell, March 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F323EB83-E975-471D-85BC-E4005FB5B657</gtr:id><gtr:impact>Attended Women in STEM conference, Harwell


Raised awareness of women in science</gtr:impact><gtr:outcomeId>DtTZiRx9zfX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Network magazine article July 2011</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>51D26EA9-C35B-4DEE-B993-81101F26DF65</gtr:id><gtr:impact>'Have I Got Snooze for You' - article by PO (Davies Group) in July/August 2011 MRC Network magazine


Greater MRC and public awareness of research work into circadian disruption being undertaken by FGU.</gtr:impact><gtr:outcomeId>kHUfZ2a7pFX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Foundation Day Lecture - Centre for Cellular &amp; Molecular Biology, Hyderabad, 2006</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48CA2919-6A29-4ED0-8A79-ADFCB2FFE33A</gtr:id><gtr:impact>Foundation Day Lecture - Chief Guest, 19th Foundation Day of the Centre for Cellular and Molecular Biology, Hyderabad: &amp;quot;Duchenne muscular dystrophy: past, present and future&amp;quot;

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>247A0CD50B8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patron, Oxfordshire Science Festival</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F78CCAC5-F178-4A64-9DDD-6A8A60AEA71F</gtr:id><gtr:impact>Patron, Oxfordshire Science Festival

Promoting science within the region and raising profile of the work of both the FGU and MRC</gtr:impact><gtr:outcomeId>sE6HPnHoYCg</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Telephone interview Canadian Medical Association Journal (2014)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70ACC55D-0063-4D97-9CE1-216B0BC8D3C4</gtr:id><gtr:impact>Telephone interview for Canadian Medical Association Journal for UCB and development of new disease prevention strategies

Raised awareness of the impact of genetics/genomics in clinical medicine</gtr:impact><gtr:outcomeId>544524725beaa1.68430997</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation - 10 Downing Street 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83C052E3-B7E3-41A7-8767-E50AB4897392</gtr:id><gtr:impact>&amp;quot;The genome and neuroscience&amp;quot; - Genomics Seminar - Developments in biosciences and the changing shape of the pharmaceutical sector - No. 10 Downing Street, London.

Increased awareness of the Prime Minister ad Secretary of State for Science as to developments in genetics and genomics and influenced policy for future science support.</gtr:impact><gtr:outcomeId>Md8k1J2PpxP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rosetrees Trust 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8EDBA6E1-AF3E-44A1-82F0-5A9FE4195425</gtr:id><gtr:impact>Update on utrophin work to lay members of the Rosetrees Trust board, 18th November 2011

Greater awareness by charity of latest research on Duchenne Muscular Dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>oCCdq8dbKPc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture - Sanger Institute, 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7F8515ED-A8FA-4C03-AB47-30455DDAC265</gtr:id><gtr:impact>&amp;quot;Perspectives and career experience as a successful woman in Science, Wellcome Trust Sanger Institute, Cambridge - 24th October.

Greater awareness of the potential career opportunities in medical research and opportunities for women in science. Increased profile of both the Unit and MRC.</gtr:impact><gtr:outcomeId>pKixLTUVb3W</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Duchenne Education Event , 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B75356B6-BE38-4985-B071-DE7C92DFE1A1</gtr:id><gtr:impact>&amp;quot;Duchenne muscular dystrophy: past, present and future&amp;quot; - Duchenne Education Event - Prosensa Offices, Oxford (Oxford University Begbroke Science Park, Yarnton, Kidlington).

Increasing awareness of muscular dystrophy in GLAXO SMITH KLINE as a potential company to deliver therapy for DMD.</gtr:impact><gtr:outcomeId>MJes2rLsfmm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker, Muscular Dystrophy Campaign President's Club Tribute Lunch, May 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1F2313A8-4C28-46D7-8C6D-BF3C53CA6CD6</gtr:id><gtr:impact>5 minute talk, Muscular Dystrophy Campaign President's Club Tribute Lunch - 23rd May.

Greater national awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>fJGxgjH88MP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisor for TV programme on Genetics , 2010</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F4ACEEC4-A73B-4389-A53D-CDF70119A3D5</gtr:id><gtr:impact>Acknowledged Advisor for TV Programme on Genetics, Ten Aips Asia TV.

Education of public in impact of genetics in clinical medicine</gtr:impact><gtr:outcomeId>sCXp6T4svfn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview - People Behind the Science August 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>73783417-370A-4FC9-B692-D98853BE242A</gtr:id><gtr:impact>Interview/podcast for People Behind the Science website. &amp;quot;;136: Dr. Kay Davies: Not Wasting Any Time in Search of Genetic Treatments for Muscular Dystrophy&amp;quot;

Greater awareness of women in science and research on muscular dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>5447b65edd1a24.06967304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.peoplebehindthescience.com/?s=kay+davies</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Panel member - Cheltenham Science Festival, June 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C893E0DF-AE62-401D-A65E-28C5F20D0A19</gtr:id><gtr:impact>Member of panel debating &amp;quot;Genetic Screening: Would You?&amp;quot; The Times Cheltenham Science Festival


Greater international awareness of involvement of both the FGU and MRC in genomics research</gtr:impact><gtr:outcomeId>pEAKxN3LewF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - St Edwards School, Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7E5A9B5A-791F-4A32-B115-CF3C33296299</gtr:id><gtr:impact>Lecture to school children - &amp;quot;Finding, predicting and fixing genes in the 21st century&amp;quot;

Greater awareness of the pupils as to current challenges and potential career opportunities in medical research. Increased profile of both the Unit and MRC in the local community.</gtr:impact><gtr:outcomeId>2332DD32DFF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article for The Times Newspaper, 2011</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>882C1BFB-C561-46EC-AC27-956E8C5E00C6</gtr:id><gtr:impact>&amp;quot;New muscular dystrophy drugs- must be met with plan to screen all babies.&amp;quot; An article for The Times Newspaper, 10th June 2011

Assistance in funding and raising of awareness for Duchenne Muscular Dystrophy Research and development of treatment</gtr:impact><gtr:outcomeId>SFywwCLhAZn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Anne McLaren Lecture - Kellogg College Oxford , 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2BA47F75-FC3A-44FB-9136-1588789393A4</gtr:id><gtr:impact>&amp;quot;Challenges of therapy for Duchenne muscular dystrophy&amp;quot; - Anne McLaren Lecture, Kellogg College, Oxford - 1st December.

Greater local public awareness of developments in the field and of research work being done by the Unit and MRC</gtr:impact><gtr:outcomeId>VtqRZY17ksR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Research Fortnight, July 2013</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ACDE559A-CB1D-40C6-A687-2076BFF19C36</gtr:id><gtr:impact>Interview for Research Fortnight, 29 July 2013

Greater international awareness of the work of both the FGU and MRC</gtr:impact><gtr:outcomeId>jcBcUwVowef</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.researchresearch.com/index.php?option=com_content&amp;view=article&amp;id=16&amp;Itemid=16</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar participant - 11 Downing Street, London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D6983218-3740-4C51-8AE6-1F30A79A6927</gtr:id><gtr:impact>Participated in The future wealth of the nation 3: science, engineering and technology seminar - 11 Downing Street, London.

Increasing awareness for government departments of the needs of the scientific community in the translation of their research</gtr:impact><gtr:outcomeId>836F468E1BD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 Interview - the Age of the Genome series 2010</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0728F2F9-A88A-4B86-A9D3-D1874E6D5756</gtr:id><gtr:impact>Interview broadcast on Radio 4 for a four part series aired in June/July 2010 entitled 'The Age of the Genome' presented by Richard Dawkins

Greater international awareness of involvement of both the FGU and MRC in genomics research</gtr:impact><gtr:outcomeId>ozv6CDjndQk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/p008r4l4</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Huntingdon's Disease Association of Western Australia 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B7AB14D3-0EB8-421C-A876-404CACD90D35</gtr:id><gtr:impact>&amp;quot;The journey to therapy: lessons from DMD for Huntington's disease patients&amp;quot; Huntington's Disease Association of Western Australia.

Greater public awareness of the potential of genomics in disease management</gtr:impact><gtr:outcomeId>f6T9h2rXaRo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with the BBC, 2011</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B8F4CB5F-B9D8-48F0-BCF0-97FE13F0A118</gtr:id><gtr:impact>Interview with the BBC on muscular dystrophy, January 2011

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>FyjcCyWwpMP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at &quot;Save our Sons Gala Dinner&quot;, Help Cure DMD, Australia 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF6F82E7-5D5A-4217-8077-67E254E231EC</gtr:id><gtr:impact>Speech at &amp;quot;Save our Sons Gala Dinner&amp;quot;, Help Cure DMD, Randwick, Sydney, Australia - 31st August.

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>GR51du4aoTY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Panel member - Action Duchenne conference 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>561A4DDF-2643-49C3-BC75-8B88CE7F3593</gtr:id><gtr:impact>Professor Dame Kay Davies was a panel member for &amp;quot;Ask the Duchenne Experts! Panel interactive session&amp;quot; - 12th Action Duchenne International Annual Conference, Institute of Education, London. 7th and 8th November 2014



Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>5447ba9d59b8a9.97272020</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.actionduchenne.org/conference/registration/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public talk on sleep at Oxford May Music Festival, 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E26E4A92-1FA7-423E-96AC-ED44FAA4DA4A</gtr:id><gtr:impact>Dr Peter Oliver (Davies Group) gave a public talk on sleep and circadian rhythm research at the Oxford May Music Festival at the Holywell Music Rooms, 1 May 2013


Greater public awareness of research work into circadian disruption being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>QMCEYfLVCdN</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture at the DPAG Woman's Dinner - Merton College 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4E38E1FD-EA2E-4566-AD7D-9C74F75B325B</gtr:id><gtr:impact>&amp;quot;The challenges of life as a scientist.&amp;quot; A talk at the DPAG Woman's Dinner - Merton College, Oxford. 1st June 2011

Greater awareness of muscular dystrophy research, potential career opportunities in medical research and opportunities for women in science. Increased profile of both the Unit and MRC.</gtr:impact><gtr:outcomeId>FDEgngx7b66</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Human Genome Organisation (HUGO), Houston, USA &quot;Genetic therapies for Duchenne musculary dystrophy&quot;</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>41C014E0-884F-45CA-A5D0-48E794A8D48C</gtr:id><gtr:impact>Talk explaining the various approaches for the therapy of DMD and their limitations.</gtr:impact><gtr:outcomeId>58c129b3719160.36834372</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to DMD patient group , 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5F701024-5CCC-4675-880A-A0137BC34FC9</gtr:id><gtr:impact>Lecture entitled: &amp;quot;Human genome at 10: Patient trials for Duchenne&amp;quot; - Action Duchenne 8th International Conference, London - November.

Greater awareness by charity and patient group of latest research on Duchenne Muscular Dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>b12Da7ExHX9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Oxford Science Festival, 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>50ADAD5A-AD75-4C55-9545-F9D9E8FBE0E2</gtr:id><gtr:impact>Prof Kay Davies and members of her group helped to man a stall on behalf of Muscular Dystrophy Campaign at the MRC Centenary mini-science festival held in Oxford, 22 June 2013.

Greater local public awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>EAUvPP1cKck</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research council lecture - Singapore</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B65AD73C-8B9B-4549-967E-BB1D33454C8E</gtr:id><gtr:impact>Lecture: &amp;quot;Dystrophin related proteins in Therapy for muscular dystrophy&amp;quot; to Biomedical Research Council (BMRC), Agency for Science, Technology and Research, Singapore.

Greater international awareness of muscular dystrophy research and work of both the FGU and MRC</gtr:impact><gtr:outcomeId>6D6A535E1EC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Duchenne research overview charity meeting, 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B318A77A-8578-472A-93FD-9D3FD8C9216C</gtr:id><gtr:impact>The meeting was held to bring together charities in he UK concerned with the development of therapy for Duchenne muscular dystrophy to try to coordinate activities and use peer review. This stimulate a lot of discussion about how best to use charity funds to progress therapy and how to avoid duplication of effort.

The outcome of the meeting was an agreement for more joined up working and following up meetings are being organised.</gtr:impact><gtr:outcomeId>MRwsbLpHAyT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Award presenter at The Comments Award (2014)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5BFF40A4-996A-41C6-97E3-597F0285746B</gtr:id><gtr:impact>Presenting the Science Commentator award for Editorial Intelligence at The Comments Awards, RIBA, London. 25th November. These are national awards appearing in the national press.

Greater awareness of the impact of science on society through the publication of short articles.</gtr:impact><gtr:outcomeId>544a3e169cf918.05649811</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://commentawards.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature (2012) in Women Count Charity Leaders Report</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F8B5EC23-6B71-45B2-81EC-F476A7330836</gtr:id><gtr:impact>Featured in Women Count Charity Leaders Report sponsored by Nomura (pg 33) which benchmarks the participation of women in the UK's largest charities.


Greater awareness of women in science and research on muscular dystrophy being undertaken by the Unit and MRC</gtr:impact><gtr:outcomeId>nYjP4kfhoCt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>128064</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of small molecule upregulators of utrophin for the treatment of Duchenne muscular dystrophy</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>F3C964F8-B896-44F0-8A7A-D1E4177B212A</gtr:id><gtr:outcomeId>56bb18a5ec1651.51706136</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>98791</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HFSPFellowship (Characterization of the neuropathological mechanisms underlying cerebellar ataxia EB)</gtr:description><gtr:end>2009-06-02</gtr:end><gtr:fundingOrg>Human Frontier Science Program (HFSP)</gtr:fundingOrg><gtr:id>170F6804-57AD-4A53-A578-8C9EA8A090BD</gtr:id><gtr:outcomeId>B96DC019D7C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rhodes Scholarship (JZ)</gtr:description><gtr:end>2007-09-02</gtr:end><gtr:fundingOrg>Rhodes Trust</gtr:fundingOrg><gtr:id>FF13DDC8-96E4-4EAE-95BB-A00D802E9B18</gtr:id><gtr:outcomeId>85C653C3C600</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2004-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65480</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marshall Scholarship (WM)</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Marshall Scholarship</gtr:fundingOrg><gtr:id>C6990491-02B0-47A4-B664-79385308EC22</gtr:id><gtr:outcomeId>AF1D6977E210</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>General Sir John Monash Scholarship (JM)</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>General Sir John Monash Foundation</gtr:fundingOrg><gtr:id>3D7DE3DC-6662-4F40-8C24-3B5C45CA0B39</gtr:id><gtr:outcomeId>1B6A2A2A7400</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66744</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marshall Scholarship (WTC)</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Marshall Scholarship</gtr:fundingOrg><gtr:id>0726DDDE-5AF2-4EE5-8E26-5DB210980499</gtr:id><gtr:outcomeId>5330E01F57A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>109910</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clarendon Scholarship (AB)</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>251D319A-F93C-4B49-BDFB-5CE38B8F9E85</gtr:id><gtr:outcomeId>D92A68F1A050</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>46351</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Fellowship (Upgrading U7snRN) (AG)</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>35630A3A-CA16-4CBF-A108-6D8EC7509062</gtr:id><gtr:outcomeId>E8EEC78AF100</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2844209</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Molecular analysis of neuromuscular and neurological disorders</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7922EA22-880F-4BE9-8A61-B3D3F63F4450</gtr:id><gtr:outcomeId>56bb17aca92bc9.31735687</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clarendon Scholarship (JM)</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>CE39FCF1-D1CE-43F6-9A18-C7123AF1ADB8</gtr:id><gtr:outcomeId>55D81C8EB9E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>516599</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Dorothy Hodgkin Fellowship (EB)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>B521F99F-8D8A-40C3-899D-28D68B0FBCFB</gtr:id><gtr:outcomeId>oZnAfkuegiA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>59055</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Research Training Fellowship (RJ)</gtr:description><gtr:end>2006-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CCEA7C8E-1FD8-482C-BDC1-AE8860BB3C06</gtr:id><gtr:outcomeId>BFE7439A0430</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2003-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65482</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marshall Scholarship (JS)</gtr:description><gtr:end>2009-06-02</gtr:end><gtr:fundingOrg>Marshall Scholarship</gtr:fundingOrg><gtr:id>7ECE2E8F-D054-4E50-B87E-8AB4FDDE245C</gtr:id><gtr:outcomeId>44542AE52B20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>76777</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT OXION Fellowship - Ion channels and diseases of electrically excitable cells (EB)</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F69B7431-307C-4DF0-98F9-9A4A12162634</gtr:id><gtr:outcomeId>6AC02772AD00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>91623</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust OXION DPhil Studentship (GA)</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>1C7C7530-7B91-4184-8D95-EBBA43EE2D2F</gtr:id><gtr:outcomeId>RKN34j5ecKq</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126984</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clarendon Fund Scholarship 2011 (KL)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>5B95C67B-18B9-4342-A2A6-431CBA13545E</gtr:id><gtr:outcomeId>RJ1FsAuz3uL0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>21053</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>NHMRC Fellowship (BT)</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>CECFA73D-D59A-4AA4-9961-DDE65BD72197</gtr:id><gtr:outcomeId>640E6CFAA5F0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93750</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TREAT-NMD - Translational Research in Europe - Assessment and Treatment of Neuromuscular Diseases (10m euros across 27 participants)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9DE1B164-C609-4DB2-96D9-E8D9DDF726E9</gtr:id><gtr:outcomeId>8ECA368F5320</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Oxford Nuffield Medical Clinical Research Training Fellowship (PJ)</gtr:description><gtr:end>2006-07-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>F00C4A2A-34A2-438D-B0F1-4F3DED586C8A</gtr:id><gtr:outcomeId>349457C31CC0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2003-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95826</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Motor Neurone Disease Association Studentship (MW)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:fundingRef>Davies/Oct13/6203</gtr:fundingRef><gtr:id>D65380C2-06D0-4D15-B42A-85AD0527AD36</gtr:id><gtr:outcomeId>54451d560d1190.05195249</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of utrophin modulators for DMD</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>Summit Plc</gtr:fundingOrg><gtr:id>47134C83-9BE3-4295-B32E-63295F7BE705</gtr:id><gtr:outcomeId>56bb197ba3b664.89798873</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The over expression of utrophin, a protein with very similar properties to dystrophin, has been proposed as a potential therapy for treatment of Duchenne Muscular Dystrophy. This patent is one of two describing the promoter sequence of utrophin and its use in screening for upregulators of the gene. Patent granted. This patent was licensed to Summit plc (formerly Vastox plc)</gtr:description><gtr:grantRef>MC_U137761449</gtr:grantRef><gtr:id>2407CC3D-1E8E-4076-A790-4EDA4EA3A3DA</gtr:id><gtr:impact>The over expression of utrophin, a protein with very similar properties to dystrophin, has been proposed as a potential therapy for treatment of Duchenne Muscular Dystrophy. This patent describes the promoter sequence of utrophin and its use in screening for upregulators of the gene. Patent granted. One drug is currently going into clinical trials</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BFCA1C8CCBB</gtr:outcomeId><gtr:patentId>CA2216611</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Utrophin Gene Promoter (first patented Sep 2000)</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The over expression of utrophin, a protein with very similar properties to dystrophin, has been proposed as a potential therapy for treatment of Duchenne Muscular Dystrophy. This patent is one of two describing the promoter sequence of utrophin and its use in screening for upregulators of the gene. Patent granted. This patent was licensed to Summit plc (formerly Vastox plc)</gtr:description><gtr:grantRef>MC_U137761449</gtr:grantRef><gtr:id>6ED46CCE-1E1E-4BAB-8979-18213C1AEE81</gtr:id><gtr:impact>The over expression of utrophin, a protein with very similar properties to dystrophin, has been proposed as a potential therapy for treatment of Duchenne Muscular Dystrophy. This patent describes the promoter sequence of utrophin and its use in screening for upregulators of the gene. Patent granted. One drug is currently going into clinical trials</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>0E392E0A374</gtr:outcomeId><gtr:patentId>US7205124</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Utrophin Gene Promoter (first patented Sep 2000)</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>An alliance was made between Summit plc and ISIS for the development of a therapy for Duchenne muscular Dystrophy using utrophin modulation.</gtr:description><gtr:grantRef>MC_U137761449</gtr:grantRef><gtr:id>5C5EA73F-EDE7-4D82-8939-D4173453FBE8</gtr:id><gtr:impact>Funding of research in Professor Davies's group from Summit plc</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>544a575f0af5c1.86109981</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Alliance between Summit plc and ISIS Innovation at Oxford</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Presentation at Genomics Seminar - Developments in biosciences and the changing shape of the pharmaceutical sector - No. 10 Downing Street, London - June 2012</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C3D81AB0-5EC9-43AA-9B55-4E4209EADB3B</gtr:id><gtr:outcomeId>hoPVxwpgAjY</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Roundtable discussion on a new &amp;quot;longitude&amp;quot; prize for 2014 at 10 Downing Street, London. 29th April</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>03F60F1D-D057-4364-A25E-C23657616D88</gtr:id><gtr:impact>Led to the choice of antibiotics as the subject for the prize.</gtr:impact><gtr:outcomeId>L18XRQWjW4U</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Parliamentary briefing - launch of All Party Parliamentary Group for Muscular Dystrophy inquiry report, 30 April 2014</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ACE48A9-382D-4702-BC03-550C30C764E0</gtr:id><gtr:outcomeId>5447bcee129dd4.94183736</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Dinner discussion with science minister David Willets and journalists to discuss the application of genomics in the NHS, Oct 2012</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>58369A99-54D6-4ABD-B7D0-5ABC10307D2A</gtr:id><gtr:impact>Setting up of Genome England</gtr:impact><gtr:outcomeId>FsKDew6UHxN</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type><gtr:url>http://www.genomicsengland.co.uk/about-genomics-england/the-board/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Working Group of Academy Medical Sciences on the use of animals containing human material</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C640047C-2ED2-4D89-8D15-A7564B77C251</gtr:id><gtr:outcomeId>XeWTcpUNthX</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>A drug for the upregulation of utrophin for the therapy of DMD.</gtr:description><gtr:id>2BD0E75D-E3E1-4218-9421-484A12D8378B</gtr:id><gtr:impact>In the future this is a potential treatment for DMD</gtr:impact><gtr:outcomeId>9F7B45DB63F</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>drug for utrophin up-regulation</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Plasmid DNA</gtr:description><gtr:id>4B151F58-DE1F-4846-83CD-1E70C4D1AC18</gtr:id><gtr:impact>These constructs will be used in research on the transcription mechanisms that underlie various human diseases, particularly leukaemia</gtr:impact><gtr:outcomeId>FD82866A6EE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>pCDNA3-HA-Af4 and pCDNA3-FLAG-Dot1a plasmid DNA</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>pU7snRI\JA-ex51-AOI\J-Al</gtr:description><gtr:id>87CBD8F1-A13A-4445-95CD-C48C538AE96C</gtr:id><gtr:impact>The research project for which 'the Materialsl will be used involves developing novel therapeutic strategies for inherited blindness. Antisense oligonucleotide sequences aimed at influencing splicing of genes that are mutated in patients with inherited blindness will be cloned in the vector described in the Materials, thereby generating 'Modifications/. These modifications will be used to transfect cultured cells derived from blind patients, and in animal models for inherited blindness, to test the therapeutic potential of antisense oligonucleotide-based therapy for inherited blindness.</gtr:impact><gtr:outcomeId>D1DDD40ADA8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>pU7snRI\JA-ex51-AOI\J-Al plasmid DNA</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Anti-mouse AF4 antiserum for detection of the expression of AF4</gtr:description><gtr:id>219C749D-E879-4BAE-82C5-1401FA9E8550</gtr:id><gtr:impact>Detection of the AF4 protein in the transcriptional complex containing the fIIILL-ENL or MLL-AF9 fusion proteins from conditional myeloblast cells lines expressing these oncogenes.</gtr:impact><gtr:outcomeId>7E75F63FA3A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Anti-mouse AF4 antiserum</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cardiac actin transgenic mouse strain 'Crosby'</gtr:description><gtr:id>C8B7C1BB-3DF0-4F22-9781-1A75C4035666</gtr:id><gtr:impact>Supplied to University of Western Australia. This is for collaborative work by Dr Nowak, a former CJ MArtin Fellow in the Unit. The work aims to develop a therapy for actin based muscle disease.</gtr:impact><gtr:outcomeId>903AB8C6226</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic mice - cardiac actin strain 'Crosby'</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cardiac actin transgenic mouse strain - Coco</gtr:description><gtr:id>E1D37196-867A-40B2-898F-A66B7F9FA052</gtr:id><gtr:impact>Supplied to University of Western Australia. This is for continuing collaboration led by Dr Nowak who is a former CJ Martin Fellow in the laboratory. The work should lead to therapy of actin based muscle disorders.</gtr:impact><gtr:outcomeId>1CCEE130DB9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic mice - cardiac actin strain 'Coco'</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibodies to syncoilin that work well in tissue and blots</gtr:description><gtr:id>E4D64CCC-236C-4037-8039-A118EA6481FB</gtr:id><gtr:impact>MTA currently under negotiation with University of Brussels</gtr:impact><gtr:outcomeId>ckoEJARzKU5</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Syncoilin antibodies - Nterm,Sync 1, Sync2</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Plasmids: - pWPromyo-3::ccdB - pWProunc-129::ccdB - pWProunc-119::ccdB</gtr:description><gtr:id>AD6CF471-156B-48BF-8FC0-7C6213210064</gtr:id><gtr:impact>Supplied to Northeastern University, Boston MA 02115 USA (2006), Stanford University, California (2006), University of California, San Francisco (2006), Massachusetts General Hospital, Boston (2006)and University of Alabama (2007)</gtr:impact><gtr:outcomeId>BA16070E82E</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Plasmids: pWPromyo-3::ccdB, pWProunc-129::ccdB, pWProunc-119::ccdB</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic mice - mutant skeletal actin strain D286G fused to an enhanced green fluorescent protein (EGFP) gene - Kermit</gtr:description><gtr:id>E1F616AB-464C-4695-B123-0CA0441C0C1F</gtr:id><gtr:impact>Supplied to University of Western Australia. This is for continuing collaboration led by Dr Nowak who is a former CJ Martin Fellow in the laboratory. The work should lead to therapy of actin based muscle disorders.</gtr:impact><gtr:outcomeId>B5E589FC9FE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic mice - mutant skeletal actin strain D286G 'Kermit'</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse muscle sections from wt and sync-/-</gtr:description><gtr:id>9FDF8227-EB3B-4ECA-BC4E-7DAABC63F733</gtr:id><gtr:impact>MTA currently under negotiation with University of Brussels</gtr:impact><gtr:outcomeId>rJRr8jhgtnM</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mouse Muscle sections Wt and Sync-/-</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Live Schwann-cell conditional (rat P0 promoter driven) human SOD1 expressing transgenic mice termed here P0-SOD1 mice</gtr:description><gtr:id>923828B8-186C-4479-98CD-8B616268FB1A</gtr:id><gtr:impact>Supplied to the Howard Florey Institute, University of Melbourne (2006) and Ludwig Institute for Cancer Research, La Jolla, California (2007). A former CJ MArtin Fellow is continuing his work in Australia.</gtr:impact><gtr:outcomeId>E33ACFBDE50</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>P0-SOD1 transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mutant skeletal actin transgenic mouse strain - D286G( #2375)</gtr:description><gtr:id>0C27A59F-5E50-4ED4-9434-14F2DEF832D1</gtr:id><gtr:impact>Supplied to University of Western Australia.This is for continuing collaboration led by Dr Nowak who is a former CJ Martin Fellow in the laboratory. The work should lead to therapy of actin based muscle disorders.</gtr:impact><gtr:outcomeId>F10B15BC471</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic mice - mutant skeletal actin strain D286G( #2375)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mutant skeletal actin transgenic mouse strain - D286G( #2383)</gtr:description><gtr:id>9A599ED6-9915-4D5C-A384-A30DBE3FDBAD</gtr:id><gtr:impact>Supplied to University of Western Australia.This is for continuing collaboration led by Dr Nowak who is a former CJ Martin Fellow in the laboratory. The work should lead to therapy of actin based muscle disorders.</gtr:impact><gtr:outcomeId>98A4CE6B95F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic mice - mutant skeletal actin strain D286G( #2383)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Summit Plc (formerly Vastox Plc)</gtr:companyName><gtr:description>Vastox plc had a programme for utrophin upregulation and also screens in flies and fish to drug toxicity. Summit plc now works in DMD and C. difficile: www.summitplc.com.</gtr:description><gtr:id>FE11AD78-868F-46C5-8D30-BEC5487F20FE</gtr:id><gtr:impact>A deal with BioMarin Pharmaceuticals to take a DMD utrophin up-regulation drug to market was made in 2009. This was then terminated. Summit plc have completed Phase I with new formulation of SMT C1100 with promising results. Phase 2 planned. We are now collaborating on follow on best in class compounds.</gtr:impact><gtr:outcomeId>0499D8D1ACE</gtr:outcomeId><gtr:url>http://www.summitplc.com/</gtr:url><gtr:yearCompanyFormed>2004</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>82240C55-8278-4F97-8BB6-7FC8823B0465</gtr:id><gtr:title>Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cb91d9b5f1db29dabc665314e353a66"><gtr:id>6cb91d9b5f1db29dabc665314e353a66</gtr:id><gtr:otherNames>Turner BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>78F891F0530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2133F50-4814-4DFB-8E0F-86ADB12D9F47</gtr:id><gtr:title>Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc237101c7d1786e3fa82328aaa7fb5c"><gtr:id>fc237101c7d1786e3fa82328aaa7fb5c</gtr:id><gtr:otherNames>Nowak KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>0A731B29387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC93D710-7FCD-4CC9-9AAE-8C63A52347AD</gtr:id><gtr:title>Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a298d6a10bcae6813c29a9805e5c001"><gtr:id>3a298d6a10bcae6813c29a9805e5c001</gtr:id><gtr:otherNames>Tinsley JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>g2CAwsXL3hM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFDC1281-6409-400B-BB2D-EAF7B6C4E121</gtr:id><gtr:title>The role of intermediate filament proteins in the development of neurological disease.</gtr:title><gtr:parentPublicationTitle>Critical reviews in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54d7e39b06065dbef420bc2f37ca90d0"><gtr:id>54d7e39b06065dbef420bc2f37ca90d0</gtr:id><gtr:otherNames>Kemp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0892-0915</gtr:issn><gtr:outcomeId>46FA6D4DC22</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A07A07D2-3102-4132-813F-832772DEC4C4</gtr:id><gtr:title>Oxr1 is essential for protection against oxidative stress-induced neurodegeneration.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40cee39611092d522cb9a3e28f30166"><gtr:id>b40cee39611092d522cb9a3e28f30166</gtr:id><gtr:otherNames>Oliver PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_13072_22_22028674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7483BAC-9A16-4BB9-9BFE-CC5FD29C2FC8</gtr:id><gtr:title>The robotic mouse: understanding the role of AF4, a cofactor of transcriptional elongation and chromatin remodelling, in purkinje cell function.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5d54da31f09d0f14f03b04723fdff8"><gtr:id>1d5d54da31f09d0f14f03b04723fdff8</gtr:id><gtr:otherNames>Bitoun E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>613311C3983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B886060A-52CE-4705-A083-2B4C4DB897DA</gtr:id><gtr:title>Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>935B441999A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0892BAFD-E49B-46B6-AD1A-C1C23F22B8DA</gtr:id><gtr:title>Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c4cd3230a90bb7fe58ec8e5823aee4d"><gtr:id>4c4cd3230a90bb7fe58ec8e5823aee4d</gtr:id><gtr:otherNames>McCullagh KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>5C8560ACD98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC60D1CE-4141-4F3F-8C29-C09E81A75C1F</gtr:id><gtr:title>Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41bda94ef4fcc68a41437c11403d7f83"><gtr:id>41bda94ef4fcc68a41437c11403d7f83</gtr:id><gtr:otherNames>Goyenvalle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544639f18be399.66066317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5D27BB5-598C-499D-B402-988D2F501005</gtr:id><gtr:title>A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80f4095fa6e5e88b4c63ebd2216a5685"><gtr:id>80f4095fa6e5e88b4c63ebd2216a5685</gtr:id><gtr:otherNames>Paton L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>543fd30232e6d4.27677383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F79D96CB-C81A-4BE5-BDE2-22DCAC232AF3</gtr:id><gtr:title>Syncoilin is an intermediate filament protein in activated hepatic stellate cells.</gtr:title><gtr:parentPublicationTitle>Histochemistry and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4463882d8d20eb09f18ef887e7d370"><gtr:id>bd4463882d8d20eb09f18ef887e7d370</gtr:id><gtr:otherNames>Van Rossen E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0948-6143</gtr:issn><gtr:outcomeId>543fd3015aad70.04038300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2925A07-4B86-42B0-BA79-C34A1DB32856</gtr:id><gtr:title>Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca3a9018fea5a7d42d338919c592550a"><gtr:id>ca3a9018fea5a7d42d338919c592550a</gtr:id><gtr:otherNames>Hoerder-Suabedissen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>F13B7160ED8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7154E574-7913-41B8-823E-1EF4B68DE1A4</gtr:id><gtr:title>Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19b5fd51fe7af0f838144c8e7d0f8219"><gtr:id>19b5fd51fe7af0f838144c8e7d0f8219</gtr:id><gtr:otherNames>Chancellor DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>ZrRJCLvn7NC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3A9A00B-F5A0-4B48-83BC-A7FEB860F5F4</gtr:id><gtr:title>In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feb64d6405c8d7955872aa45e2535e08"><gtr:id>feb64d6405c8d7955872aa45e2535e08</gtr:id><gtr:otherNames>Stuckey DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54463ad748a413.38935874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>701E385F-9B43-48DD-8733-418958FE6FC0</gtr:id><gtr:title>Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cb91d9b5f1db29dabc665314e353a66"><gtr:id>6cb91d9b5f1db29dabc665314e353a66</gtr:id><gtr:otherNames>Turner BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>543fd301c07c92.45350832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3BEB05A-2A2B-426C-9B4C-91B9A9A11CFF</gtr:id><gtr:title>New insights into behaviour using mouse ENU mutagenesis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40cee39611092d522cb9a3e28f30166"><gtr:id>b40cee39611092d522cb9a3e28f30166</gtr:id><gtr:otherNames>Oliver PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13072_22_22892373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BCD5DA5-F815-45CB-88D2-1EE0098DEFE4</gtr:id><gtr:title>Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9da3ee675e495fd5c6781ad96f05cde"><gtr:id>e9da3ee675e495fd5c6781ad96f05cde</gtr:id><gtr:otherNames>Clarke WT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>SxJkFx6tyqV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F242297-EA80-4671-9A98-7609955CDC4D</gtr:id><gtr:title>Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33b3a33f2507beb150e78e1e5a17353e"><gtr:id>33b3a33f2507beb150e78e1e5a17353e</gtr:id><gtr:otherNames>Zhang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>F271954013B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CDBF19B-2D57-4A3F-A03B-3EB16F8AFDF7</gtr:id><gtr:title>Utrophin up-regulation by an artificial transcription factor in transgenic mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc983202cbbf1b89b959caefacf6e519"><gtr:id>dc983202cbbf1b89b959caefacf6e519</gtr:id><gtr:otherNames>Mattei E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>36AB131DAEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92C585E7-E31F-4A2A-BD41-B2AFEC5C1E48</gtr:id><gtr:title>Behavioural characterisation of the robotic mouse mutant.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40cee39611092d522cb9a3e28f30166"><gtr:id>b40cee39611092d522cb9a3e28f30166</gtr:id><gtr:otherNames>Oliver PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>1624C411001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1424E671-1441-43DC-8E94-92D7F1E3BBD8</gtr:id><gtr:title>A motor function for the DEAD-box RNA helicase, Gemin3, in Drosophila.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/671398da747efd7dae05e8e3deb12d96"><gtr:id>671398da747efd7dae05e8e3deb12d96</gtr:id><gtr:otherNames>Cauchi RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>731A0B6BE83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFEEF311-FD56-4B06-B12B-8D5222292CCA</gtr:id><gtr:title>High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379f74a09e1bc968a9d553526ab06357"><gtr:id>379f74a09e1bc968a9d553526ab06357</gtr:id><gtr:otherNames>Vernes SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>656AD2530F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C11E1636-259D-46A0-8664-4A3AB6896083</gtr:id><gtr:title>Activation of mutant protein kinase Cgamma leads to aberrant sequestration and impairment of its cellular function.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5692c2b5579023e7eb9ca5745a745b60"><gtr:id>5692c2b5579023e7eb9ca5745a745b60</gtr:id><gtr:otherNames>Doran G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>9182C2B4B8F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0164AA93-6E1D-4270-8C82-1F3760398762</gtr:id><gtr:title>Candidate screening of the TRPC3 gene in cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f34af4d2e8574f0b217df6dd39dd652"><gtr:id>3f34af4d2e8574f0b217df6dd39dd652</gtr:id><gtr:otherNames>Becker EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>pm_13072_22_21321808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33C10549-F9FA-4AF2-911F-8B09E875C6F7</gtr:id><gtr:title>Intermediate filament-like protein syncoilin in normal and myopathic striated muscle.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c4cd3230a90bb7fe58ec8e5823aee4d"><gtr:id>4c4cd3230a90bb7fe58ec8e5823aee4d</gtr:id><gtr:otherNames>McCullagh KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>5A41C0D8E7E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>291EFD14-84A5-47D2-A25C-218CEA7DAA80</gtr:id><gtr:title>The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery.</gtr:title><gtr:parentPublicationTitle>Molecular therapy. Nucleic acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edcaff336b5cbb280931ae09d77afbaf"><gtr:id>edcaff336b5cbb280931ae09d77afbaf</gtr:id><gtr:otherNames>Eckenfelder A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>544638e1cd3eb0.15823838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C22047E9-3535-4ACC-8E3F-8C6317C6D2D1</gtr:id><gtr:title>The antioxidant protein Oxr1 influences aspects of mitochondrial morphology.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1ae91a136cc1808e002adb45e242f69"><gtr:id>e1ae91a136cc1808e002adb45e242f69</gtr:id><gtr:otherNames>Wu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>58aae8a47c8b25.49430122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F70C4CA8-BAA7-4705-83FD-AB3F96E9958F</gtr:id><gtr:title>Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7893cdecdb27d8df5417c129c83b712"><gtr:id>d7893cdecdb27d8df5417c129c83b712</gtr:id><gtr:otherNames>Gehrig SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5446395934e017.34495567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DA87B16-4B65-44AC-9EC2-A6F9DA8FD834</gtr:id><gtr:title>AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa0ff166301e1cc2c515b55f4eeda062"><gtr:id>fa0ff166301e1cc2c515b55f4eeda062</gtr:id><gtr:otherNames>Le Hir M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>54463679b69670.64770028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D46BFBB-B9EA-4C51-BBE4-11A4335687BB</gtr:id><gtr:title>A functional genetic link between distinct developmental language disorders.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379f74a09e1bc968a9d553526ab06357"><gtr:id>379f74a09e1bc968a9d553526ab06357</gtr:id><gtr:otherNames>Vernes SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>C77C39D5359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A0268C-8828-4DEF-8CB5-F529BEFB07AE</gtr:id><gtr:title>Evaluating the links between schizophrenia and sleep and circadian rhythm disruption.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a0826408356d51a67b297d066e8af4f"><gtr:id>4a0826408356d51a67b297d066e8af4f</gtr:id><gtr:otherNames>Pritchett D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>pm_13072_22_22569850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28F28658-0F5D-430B-BCEB-FA69FEC0DDB3</gtr:id><gtr:title>Molecular mechanisms of muscular dystrophies: old and new players.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a3c138a9c2bf9a342e30789d695e3f7"><gtr:id>8a3c138a9c2bf9a342e30789d695e3f7</gtr:id><gtr:otherNames>Davies KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>5DAFBBF652C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9921428D-34A8-4585-A7AE-3A36DC439FF6</gtr:id><gtr:title>Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/871c3a39414b672499b0c325da761712"><gtr:id>871c3a39414b672499b0c325da761712</gtr:id><gtr:otherNames>Martin-Rendon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>399D3745DD1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>135391A1-8EAE-4015-8B9F-269A1D880C6B</gtr:id><gtr:title>A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94c0485f896a0c3dfd9cfce870b06eb7"><gtr:id>94c0485f896a0c3dfd9cfce870b06eb7</gtr:id><gtr:otherNames>Ackerley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>1E24D34D23B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57618FE6-41A6-4F80-B661-9CB1AE913C1D</gtr:id><gtr:title>Cardiac a-actin over-expression therapy in dominant ACTA1 disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ade73ea2e70d7526d9f8069b3315b03"><gtr:id>0ade73ea2e70d7526d9f8069b3315b03</gtr:id><gtr:otherNames>Ravenscroft G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>54463679e2df24.03467128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19F25170-6CF3-4DDB-8F74-D962FEF82F50</gtr:id><gtr:title>Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb73a1601c2776118c87e5253b8af8b2"><gtr:id>cb73a1601c2776118c87e5253b8af8b2</gtr:id><gtr:otherNames>Hodges A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>03714079FE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>602F74FC-3AF8-47EB-9E7E-CD6D69C71A49</gtr:id><gtr:title>Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cb91d9b5f1db29dabc665314e353a66"><gtr:id>6cb91d9b5f1db29dabc665314e353a66</gtr:id><gtr:otherNames>Turner BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>qqyt73rh4CM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC92D361-BDAE-487D-B475-58D84CB560C1</gtr:id><gtr:title>Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3f9a307008440b8ed4b22993aa84463"><gtr:id>c3f9a307008440b8ed4b22993aa84463</gtr:id><gtr:otherNames>Yokota T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>366E835E5EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7050A9A-CEAE-4E57-B84B-5A6B65FA5556</gtr:id><gtr:title>Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379f74a09e1bc968a9d553526ab06357"><gtr:id>379f74a09e1bc968a9d553526ab06357</gtr:id><gtr:otherNames>Vernes SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>RqU5H6pQSnq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C95C62E-CEE4-4B63-88E4-7FFFDCA05784</gtr:id><gtr:title>Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/640f3a23acc5201a6abf088a5c2571bc"><gtr:id>640f3a23acc5201a6abf088a5c2571bc</gtr:id><gtr:otherNames>Baban D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>6919E1AA7FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD6278F6-C6CF-45C9-8A05-7FF737B7CA2A</gtr:id><gtr:title>Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18).</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeaf036b5660e23ffc91057604ee4cf3"><gtr:id>aeaf036b5660e23ffc91057604ee4cf3</gtr:id><gtr:otherNames>Towers PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>A815726BBE6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BAD014D-8DC7-4458-B3E1-A3C61A14A69D</gtr:id><gtr:title>Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c0ee7b319752e06e1099570139e53bb"><gtr:id>4c0ee7b319752e06e1099570139e53bb</gtr:id><gtr:otherNames>B?umer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>B3GsrAgeXMJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A4F3C8B-39F5-43A2-8199-E00F7A6B3596</gtr:id><gtr:title>Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>oPWb9SGBXhh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E24A87B-6351-465E-AD03-736BB525A508</gtr:id><gtr:title>Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41bda94ef4fcc68a41437c11403d7f83"><gtr:id>41bda94ef4fcc68a41437c11403d7f83</gtr:id><gtr:otherNames>Goyenvalle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>54463a58bb12b6.36785921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA6EEFC3-C7B8-439B-A283-37298F36003E</gtr:id><gtr:title>SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses.</gtr:title><gtr:parentPublicationTitle>Acta biochimica Polonica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ae0cf30ffd9ba00f9b5c8c78553faa6"><gtr:id>0ae0cf30ffd9ba00f9b5c8c78553faa6</gtr:id><gtr:otherNames>Johnson RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0001-527X</gtr:issn><gtr:outcomeId>B539F014576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34CAF2E1-4A08-47DC-8F79-E4D349147B9F</gtr:id><gtr:title>Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P a-synuclein BAC transgenic mouse.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b87408ab4631e28cdf76393ba4d8012b"><gtr:id>b87408ab4631e28cdf76393ba4d8012b</gtr:id><gtr:otherNames>Taylor TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>543fd302018558.48934236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F378FFE1-6318-4BBF-9FFF-DFA21AFC6DA6</gtr:id><gtr:title>The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f08010d8d2394208e5c4cc94ef34a73"><gtr:id>7f08010d8d2394208e5c4cc94ef34a73</gtr:id><gtr:otherNames>Finelli MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58aae806847397.58986108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F33BA669-810B-4954-AB3A-496E8AFF3732</gtr:id><gtr:title>Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ade73ea2e70d7526d9f8069b3315b03"><gtr:id>0ade73ea2e70d7526d9f8069b3315b03</gtr:id><gtr:otherNames>Ravenscroft G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>a1bAGyjZqJQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4490381-7C12-40BF-8542-52A67A55736A</gtr:id><gtr:title>A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bba65f07f3b0011fe38495c58c204fe"><gtr:id>8bba65f07f3b0011fe38495c58c204fe</gtr:id><gtr:otherNames>Gulston MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>DBE02164B8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B55C881-56C1-4C76-B559-767E749C9F40</gtr:id><gtr:title>Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87ccaf7154c0517fd122e1e355670e33"><gtr:id>87ccaf7154c0517fd122e1e355670e33</gtr:id><gtr:otherNames>Briese M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5F08F2730D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>767EF568-3AB7-4FB4-BC82-15C7F1E0ED52</gtr:id><gtr:title>Functional genetic analysis of mutations implicated in a human speech and language disorder.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379f74a09e1bc968a9d553526ab06357"><gtr:id>379f74a09e1bc968a9d553526ab06357</gtr:id><gtr:otherNames>Vernes SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>89B9617AA3D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1EA5B33-5216-45DC-B774-74048F57884F</gtr:id><gtr:title>Progress in therapy for Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a6cbf20c5cc231809c413715c6e77d8"><gtr:id>9a6cbf20c5cc231809c413715c6e77d8</gtr:id><gtr:otherNames>Fairclough RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn><gtr:outcomeId>ihpNLvfu5pm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05D0CBE9-7159-4787-931C-F829B0355A92</gtr:id><gtr:title>Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a5ead948521284989cf8de8f5a65c79"><gtr:id>2a5ead948521284989cf8de8f5a65c79</gtr:id><gtr:otherNames>Keays DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>7640DD2CCFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B319EEBA-1CFA-4044-8213-D94E7CF32AFA</gtr:id><gtr:title>The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5d54da31f09d0f14f03b04723fdff8"><gtr:id>1d5d54da31f09d0f14f03b04723fdff8</gtr:id><gtr:otherNames>Bitoun E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>4DD1234D771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFEAE4A9-4AE6-436C-8257-71D0EF8072EB</gtr:id><gtr:title>Syncoilin isoform organization and differential expression in murine striated muscle.</gtr:title><gtr:parentPublicationTitle>Journal of structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54d7e39b06065dbef420bc2f37ca90d0"><gtr:id>54d7e39b06065dbef420bc2f37ca90d0</gtr:id><gtr:otherNames>Kemp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1047-8477</gtr:issn><gtr:outcomeId>41F5EFBB575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EE683ED-8EB5-4958-BE18-A2B2BAD5A6EB</gtr:id><gtr:title>MLP accumulation and remodelling in the infarcted rat heart.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb54c94fd80292446d8796ffaa4da740"><gtr:id>cb54c94fd80292446d8796ffaa4da740</gtr:id><gtr:otherNames>Wilding JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>C870F7F94DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8DAD4F1-91FD-4C66-8571-F59A39E0CFDB</gtr:id><gtr:title>Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65d57fe6b8e03c618c90e8ee3f2118b8"><gtr:id>65d57fe6b8e03c618c90e8ee3f2118b8</gtr:id><gtr:otherNames>Rezniczek GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>2230C0CCE50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0963D330-A608-4487-88DC-4F467E1438D9</gtr:id><gtr:title>Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40cee39611092d522cb9a3e28f30166"><gtr:id>b40cee39611092d522cb9a3e28f30166</gtr:id><gtr:otherNames>Oliver PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>0194C7110FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64EB46D8-4F81-4C4D-AE7B-D732E03B836A</gtr:id><gtr:title>A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6998e43ca3f6fbc1993e4970929b5cee"><gtr:id>6998e43ca3f6fbc1993e4970929b5cee</gtr:id><gtr:otherNames>Jeans AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>A97E82B1FE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C67AAA40-E494-4E51-8BA9-C64FA8EE0658</gtr:id><gtr:title>Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff2ca26b387225e1507ea2445114e8b4"><gtr:id>ff2ca26b387225e1507ea2445114e8b4</gtr:id><gtr:otherNames>Chodroff RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>sHp1yLJKgpc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>699A8F71-6233-4B13-863A-5CD1E088FF43</gtr:id><gtr:title>A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f34af4d2e8574f0b217df6dd39dd652"><gtr:id>3f34af4d2e8574f0b217df6dd39dd652</gtr:id><gtr:otherNames>Becker EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>2E410DEA08C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EE7299F-653C-4C3A-824D-B2BED68F9822</gtr:id><gtr:title>AF4 is a critical regulator of the IGF-1 signaling pathway during Purkinje cell development.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5d54da31f09d0f14f03b04723fdff8"><gtr:id>1d5d54da31f09d0f14f03b04723fdff8</gtr:id><gtr:otherNames>Bitoun E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>ecnbBWmEuYB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37ACCE5E-9BF4-4833-BED5-A4B4B421918A</gtr:id><gtr:title>Generation and characterization of transgenic mice with the full-length human DMD gene.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ce9fa5faac7ab28006cd9a52229f2d6"><gtr:id>5ce9fa5faac7ab28006cd9a52229f2d6</gtr:id><gtr:otherNames>'t Hoen PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>9C9DF1C34A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C648F29F-598C-4C9D-9B65-EE7BE8C2A4AC</gtr:id><gtr:title>Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2429b632bedd79bf4ea4a09b0209d4fb"><gtr:id>2429b632bedd79bf4ea4a09b0209d4fb</gtr:id><gtr:otherNames>Sleigh JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>543fd3018becd6.99615174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C6C0A64-C67E-4A29-BB7B-FC9E316713FD</gtr:id><gtr:title>Laf4/Aff3, a gene involved in intellectual disability, is required for cellular migration in the mouse cerebral cortex.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcd63590b7ff2c298fa07a3b7185366c"><gtr:id>dcd63590b7ff2c298fa07a3b7185366c</gtr:id><gtr:otherNames>Moore JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>543fd3026532f2.97036407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47B56899-A9F9-4E9D-AB6E-20B344A93686</gtr:id><gtr:title>A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107efa5889bf1ee6a7b1ec6a653aa623"><gtr:id>107efa5889bf1ee6a7b1ec6a653aa623</gtr:id><gtr:otherNames>Court FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>243C65B48DE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E0D2295-8E22-4DE1-9CDA-4202446B2807</gtr:id><gtr:title>Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ade73ea2e70d7526d9f8069b3315b03"><gtr:id>0ade73ea2e70d7526d9f8069b3315b03</gtr:id><gtr:otherNames>Ravenscroft G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54463b4428db00.06799597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CCCF221-4E86-427C-ACCC-D642493BDD26</gtr:id><gtr:title>Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors.</gtr:title><gtr:parentPublicationTitle>Molecular biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9045b55ae29d2b47ed2ed807e187fa3d"><gtr:id>9045b55ae29d2b47ed2ed807e187fa3d</gtr:id><gtr:otherNames>Tan SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0301-4851</gtr:issn><gtr:outcomeId>pm_13072_22_22065248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>977C0B31-EB25-4DB1-8B8A-79CDA7E68F48</gtr:id><gtr:title>Spinal muscular atrophy at the crossroads of basic science and therapy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2429b632bedd79bf4ea4a09b0209d4fb"><gtr:id>2429b632bedd79bf4ea4a09b0209d4fb</gtr:id><gtr:otherNames>Sleigh JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_13072_22_22981697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C52C3647-8850-4139-93B8-BC7B38E6402E</gtr:id><gtr:title>Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a6cbf20c5cc231809c413715c6e77d8"><gtr:id>9a6cbf20c5cc231809c413715c6e77d8</gtr:id><gtr:otherNames>Fairclough RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>pm_13072_22_22571500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C4A78E6-0BCC-4ADA-8700-2F7FF5922F2F</gtr:id><gtr:title>Disrupted circadian rhythms in a mouse model of schizophrenia.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40cee39611092d522cb9a3e28f30166"><gtr:id>b40cee39611092d522cb9a3e28f30166</gtr:id><gtr:otherNames>Oliver PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_13072_22_22264613</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137761449</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>